Key result
Local L-NAME infusion blocked insulin-stimulated changes in femoral artery blood flow (84%, P<0.05) and microvascular recruitment (98%, P<0.05), and partially blocked muscle glucose uptake (34%, P<0.05).
Why the study?
Does local NOS inhibition impair vascular and metabolic actions of insulin in rat hindleg muscle?
Does local NOS inhibition impair vascular and metabolic actions of insulin in rat hindleg muscle?
p-value: p=< 0.05
Insulin-mediated microvascular recruitment in skeletal muscle is dependent on local NOS activation, which is important for insulin's metabolic actions.
Animal data implicate local NOS in insulin vascular-metabolic coupling; leaves open human relevance and therapeutic targeting.
Insulin stimulates microvascular recruitment in skeletal muscle, and this vascular action augments muscle glucose disposal by ∼40%. The aim of the current study was to determine the contribution of local nitric oxide synthase (NOS) to the vascular actions of insulin in muscle. Hooded Wistar rats were infused with the NOS inhibitor N(ω)-nitro-L-arginine methylester (L-NAME, 10 μM) retrogradely via the epigastric artery in one leg during a systemic hyperinsulinemic-euglycemic clamp (3 mU·min(-1)·kg(-1) × 60 min) or saline infusion. Femoral artery blood flow, microvascular blood flow (assessed from 1-methylxanthine metabolism), and muscle glucose uptake (2-deoxyglucose uptake) were measured in both legs. Local L-NAME infusion did not have any systemic actions on blood pressure or heart rate. Local L-NAME blocked insulin-stimulated changes in femoral artery blood flow (84%, P < 0.05) and microvascular recruitment (98%, P < 0.05), and partially blocked insulin-mediated glucose uptake in muscle (reduced by 34%, P < 0.05). L-NAME alone did not have any metabolic effects in the hindleg. We conclude that insulin-mediated microvascular recruitment is dependent on local activation of NOS in muscle and that this action is important for insulin's metabolic actions.
No takes yet. Share an insight, caveat, or question.
Bradley et al. (2013) studied this question. N(ω)-nitro-L-arginine methylester (L-NAME) vs. saline infusion was evaluated on femoral artery blood flow, microvascular blood flow, and muscle glucose uptake (p=< 0.05). Local L-NAME infusion blocked insulin-stimulated changes in femoral artery blood flow (84%, P<0.05) and microvascular recruitment (98%, P<0.05), and partially blocked muscle glucose uptake (34%, P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: